Novo Nordisk
NVO
#110
Rank
C$255.43 B
Marketcap
C$57.94
Share price
-1.07%
Change (1 day)
-17.71%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): C$32.09 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are C$51.43 Billion. In 2025 the company made an earning of C$29.87 Billion, an increase over its 2024 earnings that were of C$28.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$32.09 B7.43%
2025 C$29.87 B6.28%
2024 C$28.11 B28.01%
2023 C$21.96 B57.81%
2022 C$13.91 B5.24%
2021 C$13.22 B12.38%
2020 C$11.76 B13.11%
2019 C$10.40 B-3.45%
2018 C$10.77 B1.88%
2017 C$10.57 B4.3%
2016 C$10.13 B10.32%
2015 C$9.19 B7.47%
2014 C$8.55 B3.4%
2013 C$8.27 B19.09%
2012 C$6.94 B15.58%
2011 C$6.00 B16.58%
2010 C$5.15 B25.66%
2009 C$4.10 B10.68%
2008 C$3.70 B55.82%
2007 C$2.37 B7.02%
2006 C$2.22 B19.05%
2005 C$1.86 B10.55%
2004 C$1.68 B
2002 C$1.11 B-14.39%
2001 C$1.30 B-52.82%
2000 C$2.76 B250%
1999 C$0.79 B31.21%
1998 C$0.60 B34.31%
1997 C$0.44 B11.46%
1996 C$0.40 B9.03%
1995 C$0.36 B-3.15%
1994 C$0.38 B-0.67%
1993 C$0.38 B45.38%
1992 C$0.26 B-13.81%
1991 C$0.30 B37.12%
1990 C$0.22 B-0.79%
1989 C$0.22 B26.2%
1988 C$0.17 B24.97%
1987 C$0.14 B-0.9%
1986 C$0.14 B-7.78%
1985 C$0.15 B24.87%
1984 C$0.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.93 B-69.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$49.56 B 51.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$11.10 B-66.12%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$16.15 B-50.70%๐Ÿ‡บ๐Ÿ‡ธ USA